BMRN
Price
$55.17
Change
+$1.07 (+1.98%)
Updated
Jun 27 closing price
Capitalization
10.58B
37 days until earnings call
KRYS
Price
$138.88
Change
-$3.70 (-2.60%)
Updated
Jun 27 closing price
Capitalization
4.01B
43 days until earnings call
Interact to see
Advertisement

BMRN vs KRYS

Header iconBMRN vs KRYS Comparison
Open Charts BMRN vs KRYSBanner chart's image
BioMarin Pharmaceutical
Price$55.17
Change+$1.07 (+1.98%)
Volume$3.33M
Capitalization10.58B
Krystal Biotech
Price$138.88
Change-$3.70 (-2.60%)
Volume$418.51K
Capitalization4.01B
BMRN vs KRYS Comparison Chart in %
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. KRYS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and KRYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BMRN: $55.17 vs. KRYS: $138.88)
Brand notoriety: BMRN and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 165% vs. KRYS: 112%
Market capitalization -- BMRN: $10.58B vs. KRYS: $4.01B
BMRN [@Biotechnology] is valued at $10.58B. KRYS’s [@Biotechnology] market capitalization is $4.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 2 bearish.
  • KRYS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than KRYS.

Price Growth

BMRN (@Biotechnology) experienced а +0.31% price change this week, while KRYS (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

KRYS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than KRYS($4.01B). KRYS has higher P/E ratio than BMRN: KRYS (33.30) vs BMRN (20.43). KRYS YTD gains are higher at: -11.349 vs. BMRN (-16.066). BMRN has higher annual earnings (EBITDA): 777M vs. KRYS (140M). BMRN has more cash in the bank: 1.27B vs. KRYS (617M). KRYS has less debt than BMRN: KRYS (9.66M) vs BMRN (602M). BMRN has higher revenues than KRYS: BMRN (2.95B) vs KRYS (333M).
BMRNKRYSBMRN / KRYS
Capitalization10.6B4.01B264%
EBITDA777M140M555%
Gain YTD-16.066-11.349142%
P/E Ratio20.4333.3061%
Revenue2.95B333M886%
Total Cash1.27B617M206%
Total Debt602M9.66M6,231%
FUNDAMENTALS RATINGS
BMRN vs KRYS: Fundamental Ratings
BMRN
KRYS
OUTLOOK RATING
1..100
6239
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
10041
SMR RATING
1..100
7057
PRICE GROWTH RATING
1..100
8462
P/E GROWTH RATING
1..100
9998
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (62) in the Biotechnology industry is in the same range as KRYS (71) in the Pharmaceuticals Major industry. This means that BMRN’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMRN (100) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than BMRN’s over the last 12 months.

KRYS's SMR Rating (57) in the Pharmaceuticals Major industry is in the same range as BMRN (70) in the Biotechnology industry. This means that KRYS’s stock grew similarly to BMRN’s over the last 12 months.

KRYS's Price Growth Rating (62) in the Pharmaceuticals Major industry is in the same range as BMRN (84) in the Biotechnology industry. This means that KRYS’s stock grew similarly to BMRN’s over the last 12 months.

KRYS's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as BMRN (99) in the Biotechnology industry. This means that KRYS’s stock grew similarly to BMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNKRYS
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 20 days ago
59%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 13 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXECX11.150.09
+0.81%
Empower Core Strategies Intl Eq Instl
JIGFX52.360.27
+0.52%
Janus Henderson Overseas I
VGSCX33.760.15
+0.45%
Virtus Duff & Phelps Glb Rl Estt Secs C
BQMGX24.700.07
+0.28%
Bright Rock Mid Cap Growth Instl
FNWFX88.860.20
+0.23%
American Funds New World F3

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.98%
ITOS - BMRN
49%
Loosely correlated
-0.70%
IBO - BMRN
46%
Loosely correlated
-18.26%
IONS - BMRN
42%
Loosely correlated
N/A
TECH - BMRN
40%
Loosely correlated
-1.82%
KRYS - BMRN
40%
Loosely correlated
-2.60%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-2.60%
XNCR - KRYS
54%
Loosely correlated
-3.10%
IDYA - KRYS
54%
Loosely correlated
-4.13%
CRNX - KRYS
54%
Loosely correlated
-0.10%
ACLX - KRYS
54%
Loosely correlated
+0.90%
CGON - KRYS
54%
Loosely correlated
-0.46%
More